University of Iowa affiliated companies Behavioral Diagnostics and CartilaGen are two of a dozen emerging startup companies selected to compete at the Partnering for Growth’s Biotech Innovation Showcase on March 21 in Ankeny, Iowa. The companies selected represent a cross section of biotech industry including agricultural technology, human health, animal health and bio materials.
The UI Research Foundation handled the licensing agreement that is allowing CartilaGen to commercialize innovative technology developed by James Martin, Ph.D., UI Associate Professor of Orthopedics and Rehabilitation, which uses hydrogel-based material to regenerate damaged cartilage.
Behavioral Diagnostics is bringing its revolutionary approach to the treatment and prevention of substance abuse disorders to the marketplace with the assistance of UI Ventures. The company was co-founded by Rob Philibert, M.D., Ph.D., UI Professor of Psychiatry.
The competition is sponsored by the Biotechnology Innovation Organization and is a feature of the Iowa Biotech Association’s annual Partnering for Growth biotech investor conference and industry forum. The March 21-22 event is geared around learning, investing and networking with multiple sectors of the biotech industry. Robert Zolynas, Bayer Health Care, and Mike Stern, Climate Corp., are the keynote speakers for the 2017 event.
More information on the 2017 Partnering for Growth event is available here: http://www.iowabio.org/en/resources/partnering_for_growth_2017/
The UI Research Foundation and UI Ventures are part of the Office of the Vice President for Research and Economic Development provides resources and support to researchers and scholars at the University of Iowa and to businesses across Iowa with the goal of forging new frontiers of discovery and innovation and promoting a culture of creativity that benefits the campus, the state, and the world. More at http://research.uiowa.edu, and on Twitter: @DaretoDiscover , @_UIRF.